Search

everythinglearnresearchcommunity

for

Search:↓

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Nivolumab can cause hair loss as a rare side effect.

Mesalazine may help treat extensive alopecia areata effectively.

88% phenol is effective for treating alopecia areata.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Stress can trigger or worsen alopecia areata.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

Too much epidermal growth factor can cause hair loss.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

miR-199a-3p controls hair growth and is linked to alopecia areata.